Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives

A series of novel 2-aryl benzothiazole derivates substituted with iodine in different positions have been synthesized as amyloid-binding ligands. The affinity of these compounds for synthetic amyloid β (1–40) (Aβ[1–40]) fibrils was determined. Introduction of the iodo group in the position ortho to an amino group increased the binding affinity, whereas the iodination ortho to a hydroxyl group decreased the binding affinity. Selected compounds with high binding affinity and moderate lipophilicity (logP values, 1.65–3.90) were radiolabeled and evaluated in normal mice for brain uptake and clearance. Structure-activity relationship (SAR) studies showed a strong correlation between the lipophilicity of the iodinated compounds and the binding affinity as well as nonspecific binding. As the lipophilicity increased, the affinity for Aβ(1–40) fibrils improved; however, nonspecific binding in mouse brain reflected by low brain clearance also increased with increasing lipophilicity. These results provide important SAR information to guide the development of novel amyloid-binding agents and provide further insights into the molecular interaction between 2-aryl benzothiazole ligands and Aβ fibrils.

[1]  B. Hyman,et al.  Imaging Aβ Plaques in Living Transgenic Mice with Multiphoton Microscopy and Methoxy‐X04, a Systemically Administered Congo Red Derivative , 2002, Journal of neuropathology and experimental neurology.

[2]  G. Curran,et al.  Targeting Alzheimer amyloid plaques in vivo , 2000, Nature Biotechnology.

[3]  J. Trojanowski,et al.  Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates. , 2001, Journal of medicinal chemistry.

[4]  David J. Cummins,et al.  Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  W. Klunk,et al.  Synthesis and 11C-labelling of (E,E)-1-(3′,4′-dihydroxystyryl)-4-(3′-methoxy-4′-hydroxystyryl) benzene for PET imaging of amyloid deposits†† , 2002 .

[6]  D. Selkoe,et al.  Imaging Alzheimer's amyloid , 2000, Nature Biotechnology.

[7]  R. Copeland,et al.  Progress towards testing the amyloid hypothesis: inhibitors of APP processing. , 2001, Current opinion in drug discovery & development.

[8]  W. Klunk,et al.  Synthesis and evaluation of 2-(3'-iodo-4'-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in Alzheimer's disease. , 2002, Journal of molecular neuroscience : MN.

[9]  W. Klunk,et al.  X-34, A Fluorescent Derivative of Congo Red: A Novel Histochemical Stain for Alzheimer's Disease Pathology , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[10]  M. Raichle,et al.  Relationship between lipophilicity and brain extraction of C-11-labeled radiopharmaceuticals. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  J. Burke,et al.  Weak bases in strong acids. III. Heats of ionization of amines in fluorosulfuric and sulfuric acids. New general basicity scale , 1970 .

[12]  W. Klunk,et al.  Synthesis and evaluation of 2-(3′-lodo-4′-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in alzheimer’s disease , 2002, Journal of Molecular Neuroscience.

[13]  J. Doucet,et al.  Influence de la structure des cetones et de l'acidite des phenols sur leur mode de complexation: Partie I. Comportement global et échelles d'acidité et de basicité , 1989 .

[14]  William E. Klunk,et al.  The Binding of 2-(4′-Methylaminophenyl)Benzothiazole to Postmortem Brain Homogenates Is Dominated by the Amyloid Component , 2003, The Journal of Neuroscience.

[15]  G. Flynn Substituent Constants for Correlation Analysis in Chemistry and Biology. , 1980 .

[16]  R. Motter,et al.  Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease , 2000, Nature Medicine.

[17]  W. Klunk,et al.  Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. , 2001, Life sciences.

[18]  D. Selkoe Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[19]  Bin Zhang,et al.  In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease. , 2000 .

[20]  Brian J Bacskai,et al.  A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. , 2002, Bioorganic & medicinal chemistry letters.

[21]  John Comer,et al.  Lipophilicity Profiles: Theory and Measurement , 2007 .

[22]  P. Seubert,et al.  beta-peptide immunization: a possible new treatment for Alzheimer disease. , 2000, Archives of neurology.

[23]  Gerd Folkers,et al.  Pharmacokinetic Profiling in Drug Research , 2006 .

[24]  J. Pettegrew,et al.  Development of small molecule probes for the Beta-amyloid protein of Alzheimer's Disease , 1994, Neurobiology of Aging.